Partner since: 1997
Total Donated: More than $6 million in cash support and $3.7 million in product donations
For over fourteen years, global medical technology company BD has been a pioneer among UNICEF’s private partners in its support to eliminate maternal and neonatal tetanus, demonstrating the company's commitment to bringing an end to preventable deaths among hundreds of thousands of children in some of the poorest countries on earth.
BD’s philosophy toward philanthropy and community relations mirrors the company’s focus in helping people everywhere to live healthy lives. This is achieved through longstanding relationships with nonprofit organizations: through corporate grants, lifesaving product donations, and an employee volunteer service initiative. BD focuses on improving health care around the world and providing disaster relief.
Making the Elimination of Tetanus a Reality
Maternal and Neonatal Tetanus (MNT) remain one of the most pressing issues facing child survival in the developing world, but with the support of BD, the achievement of global elimination is a reachable goal.
While routine vaccination in the United States has virtually eliminated tetanus as a threat in the daily lives of Americans, nearly 100,000 mothers and newborns still die needlessly from this preventable disease each year. One infant dies from neonatal tetanus every four minutes, and their mothers often perish as well. To eliminate MNT, BD helped support the systematic implementation of a vaccination campaign that targeted 42 nations where the disease remains a major health threat. By providing intensive outreach to remote regions and countries battling extreme poverty, BD is also creating in-roads and foundations in these communities for improved health services that will impact children for future generations.